EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

A PREREQUISITE FOR ADDRESSING THE THERAPEUTIC DILEMMA OF CONTINUATION OF ANTIPLATELET THERAPY FOLLOWING AN INTRACRANIAL HEMORRHAGE? – A CASE STUDY REPORT

Krishnaja R. J., Lekshmi Johnson Maithyli and Dr. Babitha M.*

ABSTRACT

An intracranial hemorrhage is the bleed within the brain. Many patients with Intracranial hemorrhage may either suffer from history of ischemic events or ischemic pathologies which may frequently require antithrombotic therapy. This case study focuses on a patient with primary intracranial hemorrhage with a risk of thromboembolic pathology, demanding antiplatelet therapy, which is analysed here to illustrate the therapeutic dilemma of prescribing antiplatelets following the intracranial hemorrhage. At the time of admission , considering the severity of bleeding, antiplatelet medications which has been taken by the patient were withheld. Management is then mainly done according to standardized therapeutic management of Intracranial hemorrhage. Patient’s condition then improves and the patient is discharged without giving antipaltelets. But in this case, after 4 months the patient started showing thrombotic symptoms like dysarthria, weakness along with elevated blood pressure which increased the demand for antiplatelet therapy and started aspirin 75mg. After 7 weeks, the patients condition deteriorated and was readmitted with hemorrhagic stroke. This case study raises an important question regarding the continuation of an effective and safe antiplatelet medication in high thromboembolic risk patient who is in a post recovery period from an intra cerebral hemorrhage. In our case study we conclude that this particular dilemma requires a higher clinical research attention and a well designed randomized control trial which should be performed to make an authenticated advise to patients.

Keywords: Intracranial hemorrhage, antiplatelets, hemorrhagic stroke, thrombo embolic risk, therapeutic dilemma, case study.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: DECEMBER ISSUE PUBLISHED

    DECEMBER Issue has been successfully launched on 1 December 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )